ArticleJournal for immunotherapy of cancer2021

CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.

Moran Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.